Jonathan Gardner
Senior Reporter | @ByJonGardner
585 articles by Jonathan Gardner
-
Sanofi, GSK say dual-acting vaccine prevents COVID-19 from omicron in large trial
June 24, 2022 -
UniQure buoyed by early data for Huntington's gene therapy
June 23, 2022 -
Pfizer takes stake in Lyme disease partner ahead of key study
June 21, 2022 -
Pharma under the microscope as FTC considers new ways to review acquisitions
June 16, 2022 -
FDA staff supportive of Pfizer, Moderna COVID vaccines in young children
June 13, 2022 -
GSK claims first positive Phase 3 result for an RSV vaccine
June 10, 2022 -
Alnylam follows rivals with new study results for kidney disease drug
June 9, 2022 -
FDA advisers back Novavax's latecomer COVID-19 vaccine
June 7, 2022 -
Roche keeps the faith in new cancer immunotherapy despite trial setbacks
June 7, 2022 -
Bristol Myers bets $4B on Turning Point and its targeted cancer drugs
June 3, 2022 -
Regeneron buys control of cancer drug Libtayo from Sanofi
June 2, 2022 -
Bristol Myers' autoimmune drug shows potential in lupus
June 1, 2022 -
Roche SMA drug approved in youngest infants, challenging Novartis and Biogen
May 31, 2022 -
Merck study results signal blood cancer potential for new type of immunotherapy
May 26, 2022 -
Pfizer pledges not-for-profit sale of medicines in low-income countries
May 25, 2022 -
Responding to outbreak, Moderna starts early work on monkeypox vaccine
May 24, 2022 -
Pfizer says 3 doses of its COVID-19 vaccine works in youngest children
May 23, 2022 -
PTC's first gene therapy gains European regulator's backing
May 20, 2022 -
Trial setback casts doubt on a biotech's respiratory virus drug
May 19, 2022 -
Scientists home in on cause of Duchenne gene therapy side effect
May 17, 2022 -
Lilly wins FDA approval for new kind of diabetes drug
May 13, 2022 -
NIH licenses COVID-19 technologies to WHO-backed program
May 13, 2022 -
Key Bristol Myers drug holds up in long-term psoriasis study
May 12, 2022 -
With spotlight on FDA, Congress weighs reforms to accelerated drug approvals
May 10, 2022 -
Pfizer cleared to restart hemophilia gene therapy trial
May 3, 2022